EESMO Open3/17/2026

377P Risk prediction for non-small cell lung cancer using longitudinal EMR data: A machine learning model in a national Israeli cohort

Background: To assess the performance of an in-house developed AI Large Language Model (LLM) in assisting lung cancer patient management and compare its efficiency and accuracy against manual clinical workflows. Methods:We conducted a retrospective study on 849 consecutive lung cancer patient MDT records form Feb. 2025 to Dec. 2025.Our proprietary AI "Lung Cancer LLM" performed several tasks: rapid document scanning, structured data extraction, treatment suggestion generation, recurrence risk pr